1. Home
  2. THAR vs GV Comparison

THAR vs GV Comparison

Compare THAR & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • GV
  • Stock Information
  • Founded
  • THAR 2017
  • GV 2013
  • Country
  • THAR United States
  • GV Canada
  • Employees
  • THAR 3
  • GV N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • GV Other Consumer Services
  • Sector
  • THAR Health Care
  • GV Real Estate
  • Exchange
  • THAR Nasdaq
  • GV Nasdaq
  • Market Cap
  • THAR 16.8M
  • GV 6.3M
  • IPO Year
  • THAR 2022
  • GV 2022
  • Fundamental
  • Price
  • THAR $3.14
  • GV $1.70
  • Analyst Decision
  • THAR Strong Buy
  • GV
  • Analyst Count
  • THAR 1
  • GV 0
  • Target Price
  • THAR $17.00
  • GV N/A
  • AVG Volume (30 Days)
  • THAR 29.4M
  • GV 73.5K
  • Earning Date
  • THAR 11-06-2025
  • GV 09-26-2025
  • Dividend Yield
  • THAR N/A
  • GV N/A
  • EPS Growth
  • THAR N/A
  • GV N/A
  • EPS
  • THAR N/A
  • GV N/A
  • Revenue
  • THAR N/A
  • GV $7,773,905.00
  • Revenue This Year
  • THAR N/A
  • GV N/A
  • Revenue Next Year
  • THAR N/A
  • GV N/A
  • P/E Ratio
  • THAR N/A
  • GV N/A
  • Revenue Growth
  • THAR N/A
  • GV N/A
  • 52 Week Low
  • THAR $0.95
  • GV $1.00
  • 52 Week High
  • THAR $9.08
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • THAR 48.05
  • GV 54.07
  • Support Level
  • THAR $2.75
  • GV $1.45
  • Resistance Level
  • THAR $3.46
  • GV $1.57
  • Average True Range (ATR)
  • THAR 1.23
  • GV 0.12
  • MACD
  • THAR -0.32
  • GV 0.00
  • Stochastic Oscillator
  • THAR 6.16
  • GV 84.62

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: